Continuous monitoring of movement symptoms using a wearable device called the Personal KinetiGraph (PKG) may help clinicians make more appropriate treatment…
Neurocrine Biosciences and Voyager Therapeutics have joined efforts in a new strategic collaboration to further develop and market…
Biogen and C4 Therapeutics (C4T) have joined efforts to develop therapies using a cell’s natural protein degradation system…
Parkinson’s patients show less ability to participate in work life even in the early stages before they are…
Rodin Therapeutics has started a Phase 1 clinical trial to explore the safety of its synthetic compound, RDN-929, to…
Voyager Therapeutics has begun patient dosing in a Phase 2 trial testing its investigational VY-AADC gene therapy in Parkinson’s patients…
Older patients with inflammatory bowel disease (IBD) are more likely to develop Parkinson’s disease than those without the condition, a…
Impaired sense of smell or taste can raise a person’s risk of developing Parkinson’s disease 2.5 times, a study suggests.
Essential oil extract from the leaves of a Brazilian plant can protect nerve cells from damage and prevent progressive physical…
Mission Therapeutics and AbbVie have established a new partnership aimed at developing specific inhibitors targeting deubiquitylating enzymes, or DUBs, for…
Get regular updates to your inbox.
